Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes.

Diabetes & metabolic syndrome - 1 Jan 2000

Camara Soumaïla, Bouenizabila Evariste, Hermans Michel P, Ahn Sylvie A, Rousseau Michel F

Abstract excerpt

BACKGROUND: T2DM management requires tight control of 3 critical quality indicators to prevent vascular complications: LDL-C, SBP, and HbA1c. This study evaluated the rate of T2DM patients attaining these critical quality indicators, and the pathophysiological or cardiometabolic traits predicting goal achievement. PATIENTS AND METHODS: Cross-sectional analysis evaluating combined goal achievement (LDL-C<100...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Belgium
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Diabetes Mellitus, Type 2

Share to Diabetic Angiopathies

Share to Dyslipidemias

Share to Glycated Hemoglobin

Share to Insulin-Secreting Cells

Source

Identifiers

PMID: 25220917
DOI: 10.1016/j.dsx.2014.04.037

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes.PMID 25220917Read ↗

Cardiovascular risk management: the success of target level achievement in high- and very high-risk patients in HungarySemantic proximity Read ↗

Fasting insulin predicts cardiovascular mortality in pre-diabetes and remains elevated across type 2 diabetes: An NHANES 2007–2018 cohort analysisSemantic proximity Read ↗

Risk of cardiovascular events associated with pathophysiological phenotypes of type 2 diabetes.Semantic proximity Read ↗

SGLT2 inhibition in addition to lifestyle intervention and risk for complications in subtypes of patients with prediabetes - a randomized, placebo controlled, multi-center trial (LIFETIME) – rationale, methodology and designSemantic proximity Read ↗

Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settingSemantic proximity Read ↗

Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: Results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortiumSemantic proximity Read ↗

Exercise as targeted therapy in type 2 diabetes: a phenotype-informed clinical prioritisation framework for adapted physical activity.Semantic proximity Read ↗

Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetes.Semantic proximity Read ↗

The association of body weight change and regression to normoglycemia in different phenotypes of pre-diabetes: Findings of a longitudinal cohort study.Semantic proximity Read ↗

Phenotypic characterization of normotolerant hypertensive patients.Semantic proximity Read ↗

Impact of A Two-Year Trial of Nutritional Ketosis on Indices of Cardiovascular Disease Risk in Patients With Type 2 DiabetesSemantic proximity Read ↗

Association of Low Fasting C-Peptide Levels With Cardiovascular Risk, Visit-To-Visit Glucose Variation and Severe Hypoglycemia in The Veterans Affairs Diabetes Trial (VADT)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.